3957 POINT EDEN WAY, HAYWARD, CA
Election of Seven Directors and Ratification of Deloitte Appointment
Announces Planned Redemption of Warrants
Other Events
Financial Results, Other Events
Investor Presentation
Strengthens Executive Leadership Team
Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
Q1
FY 2024
Q3
Q2
Amended Annual Report
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Additional Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Specialized Disclosure Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload